A Phase 1 trial shows a personalized DNA vaccine (GNOS-PV01) is safe and doubles survival rates for aggressive glioblastoma.

Survival rate surpasses historical outcomes in a small phase I study ...

A personalized DNA vaccine for glioblastoma, an aggressive and incurable brain cancer, appears safe and shows early signs of ...

Researchers have developed a drug shown to significantly extend survival time for patients with glioblastoma, the most common primary brain tumor in adults, according to results of a new trial. A drug ...

Michael Bolton’s battle with glioblastoma has brought renewed attention to one of the most complex, deadly and treatment-resistant cancers. The singer, 72, told People he was diagnosed in December ...

Reoperation in recurrent glioblastoma patients may improve progression-free and overall survival, especially when tumors are in non-eloquent, accessible brain regions. Factors like age, gender, tumor ...

Temferon demonstrated potential in glioblastoma treatment, with long-term survivors and improved survival rates compared to historical data. The therapy reprograms the tumor microenvironment, inducing ...

A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for ...

Glioblastoma, the most aggressive malignant brain tumor in adults, is not an isolated lesion, but a disease that destabilizes the brain's communication network. A new study published in the journal ...